HEPA - Hepion Pharmaceuticals, Inc.
0.318
-0.074 -23.145%
Share volume: 4,368,896
Last Updated: 05-12-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$0.39
-0.07
-0.19%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-21-2024 | 08-13-2024 | 11-14-2024 | 05-19-2025 | 08-14-2025 | 11-12-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | |||
| Operating expenses | 5.182 M | 8.504 M | 4.458 M | 1.281 M | 1.343 M | 527.902 K | |
| Selling general and admin | 2.643 M | 1.367 M | 1.696 M | 1.258 M | 919.488 K | 527.902 K | |
| Research and development | 2.540 M | 7.137 M | 2.763 M | 22.235 K | 423.277 K | 0.000 | |
| Total expenses | 5.182 M | 8.504 M | 4.458 M | 1.281 M | 1.746 M | 527.902 K | |
| 64.09% | -47.57% | -71.28% | 36.30% | -69.76% | |||
| Operating income | -5.182 M | -8.504 M | -4.458 M | -1.281 M | -1.746 M | -527.902 K | |
| Ebit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Pretax income | -5.823 M | -3.925 M | -4.866 M | -6.106 M | -1.043 M | -472.506 K | |
| -32.59% | 23.97% | 25.48% | -82.93% | -54.68% | |||
| Income tax | -2.969 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.854 M | -3.925 M | -4.866 M | -6.106 M | -1.043 M | -472.506 K | |
| -37.54% | -23.97% | -25.48% | 82.93% | 54.68% |